FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Oncogene. 2017 Sep 21;36(38):5439. doi: 10.1038/onc.2017.249. Epub 2017 Jul 17.

Authors

D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee

PMID: 28714963
DOI: 10.1038/onc.2017.249

Abstract

This corrects the article DOI: 10.1038/onc.2014.184.

Publication types

Published Erratum